Vanda Pharmaceuticals (VNDA) OCF US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
OCF, bln rub | ? | 45.9 | 51.8 | 64.2 | 32.0 | 12.8 | -11.4 | ||
Changes by years, y/y, % | +53% | +13% | +24% | -50% | -60% | -15.7% |
Vanda Pharmaceuticals. OCF, bln rub
Vanda Pharmaceuticals. OCF, changes, %
Vanda Pharmaceuticals. OCF, sum by quarters, bln rub
Vanda Pharmaceuticals (VNDA) OCF US GAAP (quarter values) |
||||||||
2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
OCF, bln rub | ? | 31.8 | -13.2 | -2.05 | -3.73 | 7.57 | -11.4 | |
Changes by years, y/y, % | +686% | -333% | -116% | -140% | -76% | |||
Changes by quarters, q/q, % | +238% | -142% | -84% | +82% | -303% |